The University of Chicago Header Logo

Connection

James L. LaBelle to Antibodies, Neoplasm

This is a "connection" page, showing publications James L. LaBelle has written about Antibodies, Neoplasm.
Connection Strength

0.057
  1. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood. 2004 Mar 01; 103(5):1969-71.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.